|
MechanismH1 receptor antagonists |
|
Originator Org.- |
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Russia |
First Approval Date01 Jan 1983 |
Multicenter Randomized Double-blind Placebo-controlled Three-arm Parallel-group Clinical Study to Evaluate the Efficacy and Safety of DMB-I in the Treatment of Dementia Associated With Alzheimer's Disease
The purpose of this study is to assess the efficacy and safety of DMB-I for the treatment of patients with Alzheimer type dementia.
100 Clinical Results associated with Bigespas Ltd.
0 Patents (Medical) associated with Bigespas Ltd.
100 Deals associated with Bigespas Ltd.
100 Translational Medicine associated with Bigespas Ltd.